EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes

Kavita Raniga, Aishah Nasir, Nguyen T N Vo, Ravi Vaidyanathan, Sarah Dickerson, Simon Hilcove, Diogo Mosqueira, Gary R Mirams, Peter Clements, Ryan Hicks, Amy Pointon, Will Stebbeds und 2 weitere

Cell Stem Cell · 2024-03 · 31 (3) · 292-311

DOI: 10.1016/j.stem.2024.01.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Stem Cell, 2024-03. Verfasst von Kavita Raniga und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK; Pathology, Non-Clinical Safety, GlaxoSmithKline R&D, Stevenage SG1 2NY,…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Animal Free Research UK, British Heart Foundation, National Centre for the Replacement, Refinement and Reduction of Animals in Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacInduced Pluripotent Stem CellsHumansCell Differentiation

Stichwörter der Autor:innen

cardiomyocyte contractioncardiotoxicityhuman-induced pluripotent stem cell-derived cardiomyocytesin vitro complex modelsregenerative therapies

Autor:innen und Institutionen

  • The Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK; Pathology, Non-Clinical Safety, GlaxoSmithKline R&D, Stevenage SG1 2NY, UK. Electronic address: kh.raniga@gmail.com.
  • The Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.
  • FUJIFILM Cellular Dynamics, Inc., Madison, WI, USA.
  • Centre for Mathematical Medicine & Biology, School of Mathematical Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
  • Pathology, Non-Clinical Safety, GlaxoSmithKline R&D, Stevenage SG1 2NY, UK.
  • BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; School of Cardiovascular and Metabol…

Förderung

  • Animal Free Research UK
  • British Heart Foundation
  • National Centre for the Replacement, Refinement and Reduction of Animals in Research
  • GlaxoSmithKline
  • AstraZeneca
  • Wellcome Trust

Zitieren

APA

Raniga, K., Nasir, A., Vo, N. T. N., Vaidyanathan, R., Dickerson, S., Hilcove, S., Mosqueira, D., Mirams, G. R., Clements, P., Hicks, R., Pointon, A., Stebbeds, W., Francis, J., & Denning, C. (2024). Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell, 31(3), 292-311. https://doi.org/10.1016/j.stem.2024.01.007

Vancouver

Raniga K, Nasir A, Vo NTN, Vaidyanathan R, Dickerson S, Hilcove S, et al. Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. 2024;31(3):292-311. doi:10.1016/j.stem.2024.01.007

BibTeX
@article{Raniga2024,
  author = {Raniga, Kavita and Nasir, Aishah and Vo, Nguyen T N and Vaidyanathan, Ravi and Dickerson, Sarah and Hilcove, Simon and Mosqueira, Diogo and Mirams, Gary R and Clements, Peter and Hicks, Ryan and Pointon, Amy and Stebbeds, Will and Francis, Jo and Denning, Chris},
  title = {Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes},
  journal = {Cell Stem Cell},
  year = {2024},
  volume = {31},
  number = {3},
  pages = {292--311},
  doi = {10.1016/j.stem.2024.01.007}
}
Kostenlos starten →